Clinical Trial

Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Phase III, international multicentre, parallel group, blinded, 1:1 randomized controlled trial to determine the effect of an intraoperative intravenous lidocaine infusion on reducing the development of persistent pain 3-months after breast cancer surgery.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2021-04-30; most recent amendment 2026-06-17.
Status change: Not Yet Recruiting → Recruiting 2021-10-04
Trial Details
NCT Number NCT04874038
Lead Sponsor University Health Network, Toronto
Collaborators: Canadian Institutes of Health Research (CIHR)
Conditions Post-mastectomy Pain Syndrome, Breast Cancer, Pain, Postoperative, Pain, Chronic
Enrollment 1,602 participants
Start Date 2021-09-22
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-11-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-22